Approval · Notice of Compliance 24681 · 2020
PIMOZIDE: Notice of Compliance 24681
Issued November 26, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24681
- Date
- November 26, 2020
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Change in drug product specifications
- Canadian reference product
- ORAP (Janssen-Ortho Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PIMOZIDE | Not yet assigned | — |